Latest Conference Articles

Robert Frantz, MD, FACC, Director, Pulmonary Hypertension Clinic, Mayo Clinic, discusses the rate of bloodstream infections in patients with pulmonary arterial hypertension treated with Veletri. Dr Franz also talks about the PROSPECT registry analysis.

Cost has been front of mind for many researchers that have released new study data at CHEST 2012. Here are some of the highlights from the new research.

Brian Carlin, MD, FCCP, Allegheny General Hospital, discusses the challenges in reducing 30-day readmission rates, specifically as they apply to congestive heart failure, pneumonia, and COPD. The biggest challenge is setting up a coordinated team care effort, says Dr Carlin.

Hundreds of new abstracts were published for CHEST 2012. Here are some of the highlights around the topic of quality of life as they relate to various disease states.

In this video, Aaron McKethan, PhD, Vice President, Strategy and Business Development, RxAnte, talks about new strategies to improve patient medication adherence.

There exists a need for a standard of care to ensure that each patient's medications are appropriate, effective, safe, and able to be taken as intended. Medication therapy management (MTM) is a professional service that can help meet this need. Although the practice of providing comprehensive MTM services by phone has many positive attributes, there are many challenges associated with this type of intervention.

Brian Sweet, RPh, MBA, Executive Director, Health Care Alliances, AstraZeneca Pharmaceuticals, talks about the progress that has been made to-date in integrating clinical data elements with administrative claims data.

Medication assessments directly impact the way a drug is covered, and drugs with better quality data with a higher level of certainty are more favorably covered. Accurately assessing the evidence for new medications will help payers summarize a drug's benefit-to-risk ratio.

In this video, Aimee Tharaldson, PharmD, Senior Clinical Consultant, Emerging Therapeutics Express Scripts, Inc, talks about the impact that biosimilar medications could potentially have on the specialty pharmacy market.

In this video, Feng Zeng, PhD, Senior Health Economist, MedImpact, discusses how the implementation of copayment reduction in the gap in 2011 influenced adherence measures for oral diabetes medications.

The role of the pharmacist in the care of patients with cancer is evolving. Pharmacists can help optimize treatment outcomes for each patient through use of patient-specific and disease-specific strategies.

In this video, David Nau, PhD, talks about data challenges as they relate to medication adherence measures. "One data challenge that Medicare plans face is getting all of the prescription field data from the pharmacist," says Dr. Nau.

Managed care pharmacists can help optimize outcomes in patients with age-related eye disease by addressing concerns regarding affordability of therapy, instructing patients on proper eye drop instillation, and evaluating the effects of different therapies. Ophthalmologists and optometrists should take part in managed care formulary discussions to help achieve optimal patient care.

In this video, Mark Zitter, MBA, talks about the implications of Co-Pay Offset Programs for managed care. "Co-pay programs affect managed care very differently depending on the nature of the program," says Zitter. "These programs are tremendously varied."

During a preconference session at the Academy of Managed Care Pharmacy (AMCP) 2012 Educational Conference in Cincinnati, Ohio, industry experts met to discuss the ways in which heterogeneity shapes therapeutic decisions, patient outcomes, and coverage policies.

The Academy of Managed Care Pharmacy's (AMCP) 2012 Educational Conference will take place in Cincinnati, OH, October 3-5 at the Duke Energy Convention Center.

Len Nichols, PhD, Professor of Health Policy and Director, GMU Center for Health Policy Research and Ethics, College of Health and Human Services, George Mason University, says that if states do not expand their Medicaid programs half of the uninsured will continue without coverage. States will continue to pay for healthcare inefficiently while patients receive suboptimal care.

Although there are contentions regarding its mechanisms, health policy and managed care authorities agree that the ultimate goal of healthcare reform is to increase access, improve quality, decrease costs, and measure progress. The initiative of further integrating digital health systems and implementing health information technology continues to receive substantial support and growth in a positive direction.

Peter Cunningham, PhD, Senior Fellow and Director of Quantitative Research, Center for Studying Health System Change, says that delivery systems should be moved more towards care management in order to deal with the high levels of wasteful care and emergency room use associated with Medicaid.

Robert Berenson, MD, FACP, Institute Fellow, Health Policy Center, Urban Institute, thinks that new healthcare delivery models are inevitable due to the behavior of physicians and providers who have abused fee-for-service. Dr. Berenson says that there has been unacceptable growth in the bias of fee-for-service activities, and new delivery models are necessary to improve quality and costs in healthcare.

The current movement toward healthcare reform is a multifaceted initiative that attempts to increase healthcare access and improve quality across the nation while balancing budgets and reducing current fiscal deficits. One health program that is a major component in the movement is Medicaid, and in this article, 2 health policy experts share their insight on the impact and future direction of Medicaid reforms.

Juliette Cubanski, PhD, Associate Director, Program on Medicare Policy, Kaiser Family Foundation, believes that the Medicare program overall has as much at stake in the 2012 election. Specifically, Dr. Cubanski says increasing private plan participation in Medicare and whether Medicare should move towards privatization will be some of the greatest challenges moving forward.

With healthcare and Medicare reform initiatives set in motion and garnering substantial momentum, mechanisms and programs for assessing improvement and determining quality measures have gained increased attention. In today's featured presentation, 2 health policy experts shared their insight on the current and future movement of performance and quality measurement.

Joseph Antos, PhD, Wilson H. Taylor Scholar in Healthcare and Retirement Policy, American Enterprise Institute, says people need to accept and understand that Medicare will not pay for all healthcare expenses after the age of 65. It is necessary to realistically look at other payment alternatives.

The abuse of government programs and misappropriation of limited healthcare resources contribute significantly to, and further complicate, the growing burden of healthcare expenditures and utilization in the United States. Government bodies have demonstrated a paradigm shift, embracing collaborations and implementing evolved strategies, to more effectively combat Medicare fraud.

Farzad Mostashari, MD, ScM, National Coordinator for Health Information Technology, US Department of Health and Human Services, says that meaningful use sets a foundation for new models to deliver care to an entire population.

As the search continues for effective cost-containment strategies in a landscape of substantial healthcare expenditures, policy authorities are looking at Medicare reform and the Part D model for opportunities and direction. In this discussion, 2 policy experts share their insights on the progress, trends, and possibilities of Medicare Part D.

Mark McClellan, MD, PhD, Director, Engelberg Center for Health Care Reform, Leonard D. Schaeffer Chair in Health Policy Studies, Brookings Institution, talks about how to better inform providers regarding regulations and quality measures that are part of new delivery care models.